FDA Releases Draft Guidance on Electronic Records and Electronic Signatures in Clinical Investigations

Summary

The US Food and Drug Administration (FDA) has published a draft guidance document outlining the agency's regulations on the use of electronic records and electronic signatures in clinical investigations of medical products, building on previous recommendations made in 2003.